Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Puma Biotechnology
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma shares nearly triple on drug news, but options smell 'fishy'
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
SEC charges former Puma biotech exec with $1.1 million in insider trading
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology falls more than 20%
Puma Biotech (NYSE: PBYI) Stock Skyrockets 300% on Breast Cancer Breakthrough
Puma Biotechnology Stock (NASDAQ:PBYI), Quotes and News Summary - Benzinga
Puma Biotechnology (NASDAQ:PBYI) Stock Price News
Former Puma Biotechnology exec is accused of making $1.2 million from insider trading - Los Angeles Times
PBYI Insider Trading Activity - Puma Biotechnology, Inc.
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotechnology Executives Under Investigation for Breast Cancer Drug — Schubert Jonckheer & Kolbe
PUMA BIOTECHNOLOGY, INC.
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Former Puma Biotech executive gets U.S. prison term for insider trading
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Why Puma Biotechnology's Shares Jumped 20% on Monday | The Motley Fool
Puma Biotechnology
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
